Consensus Development Conference
Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension
R. I. Ogilvie, E. D. Burgess, J. R. Cusson, R. D. Feldman, L. A. Leiter and M. G. Myers
CMAJ September 01, 1993 149 (5) 575-584;
R. I. Ogilvie
E. D. Burgess
J. R. Cusson
R. D. Feldman
L. A. Leiter
In this issue
Article tools
Respond to this article
Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension
R. I. Ogilvie, E. D. Burgess, J. R. Cusson, R. D. Feldman, L. A. Leiter, M. G. Myers
CMAJ Sep 1993, 149 (5) 575-584;
Related Articles
- No related articles found.
Cited By...
- Efficacy and tolerability of a {beta}-1 selective {beta} blocker, bisoprolol, as a first-line antihypertensive in Indian patients diagnosed with essential hypertension (BRIGHT): an open-label, multicentric observational study
- Les betabloquants ont-ils un role dans le traitement de l'hypertension?: NON
- Do {beta}-blockers have a role in treating hypertension?: NO
- Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
- Direct and indirect randomized trials of screening: the A's and D's of evidence-based clinical practice guidelines
- 1999 Canadian recommendations for the management of hypertension